Efficacy and Safety of Mycobacterium Indicus Pranii as an Adjunct Therapy in Category II Pulmonary Tuberculosis in a Randomized Trial
Scientific Reports - United Kingdom
doi 10.1038/s41598-017-03514-1
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 13, 2017
Authors
Publisher
Springer Science and Business Media LLC